Furthermore, BET inhibition suppresses the PD-1/PD-L1 axis, improves tumor cell-specific T cell cytotoxic function, and overcomes tumor-mediated T cell exhaustion in TNBC (172). The gene discussed is CD274; the disease is neoplasm.